Related Experiment Videos
Familial and acquired type V hyperlipoproteinemia
1Department of Internal Medicine (Lipoprotein Research), Cincinnati General Hospital, Ohio.
Atherosclerosis
|January 1, 1976
Summary
Type V hyperlipoproteinemia presents with specific clinical and biochemical features. Its inheritance pattern appears autosomal dominant, though genetic markers are not yet identified.
Area of Science:
- Lipidology
- Genetics
- Metabolic Disorders
Background:
- Type V hyperlipoproteinemia is a rare genetic disorder characterized by elevated levels of triglycerides and cholesterol.
- Understanding its clinical presentation, biochemical profile, and genetic basis is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the clinical and genetic characteristics of Type V hyperlipoproteinemia.
- To determine the mode of inheritance and identify potential genetic markers.
Main Methods:
- Retrospective analysis of 29 adult patients with Type V lipoprotein phenotype.
- Assessment of clinical presentation, biochemical parameters, and family history.
- Evaluation of metabolic stimuli contributing to hypertriglyceridemia.
Main Results:
- 23 out of 29 patients had superimposed metabolic stimuli like uncontrolled diabetes, estrogen use, pancreatitis, or ethanolism.
- After metabolic stabilization, 17 patients were diagnosed with familial hypertriglyceridemia.
- No specific genetic marker for Type V or Type IV genotypes was identified.
Conclusions:
- The inheritance pattern of Type V hyperlipoproteinemia is consistent with an autosomal dominant trait.
- Further research is needed to identify specific genetic markers for accurate diagnosis and genetic counseling.